4.6 Article

Resolvin D series and Protectin D1 mitigate acute kidney injury

Journal

JOURNAL OF IMMUNOLOGY
Volume 177, Issue 9, Pages 5902-5911

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.177.9.5902

Keywords

-

Categories

Funding

  1. NIDCR NIH HHS [P50 DE 016191] Funding Source: Medline
  2. NIDDK NIH HHS [DK 39773, DK 38452, DK 73299, DK 074448] Funding Source: Medline
  3. NIGMS NIH HHS [GM 38765] Funding Source: Medline

Ask authors/readers for more resources

Omega-3 fatty acid docosahexaenoic acid is converted. to potent resolvins (Rv) and protectin D1 (PDI), two newly identified families of natural mediators of resolution of inflammation. We report that, in response to bilateral ischemia/reperfusion injury, mouse kidneys produce D series resolvins (RvDs) and PD1. Administration of RvDs or PD1 to mice before the ischemia resulted in a reduction in functional and morphological kidney injury. Initiation of RvDs and RvD1 administration 10 min after reperfusion also resulted in protection of the kidney as measured by serum creatinine 24 and 48 h 1, ater. Interstitial fibrosis after ischemia/reperfusion was reduced in mice treated with RvDs. Both RvDs and PD1 reduced the number of infiltrating leukocytes and blocked TLR-mediated activation of macrophages. Thus, the renal production of Rv and protectins, a previously unrecognized endogenous anti-inflammatory response, may play an important role in protection against and resolution of acute kidney injury. These data may also have therapeutic implications for potentiation of recovery from acute-kidney injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available